NeoPharm CO., LTD. (KOSDAQ:092730)
21,450
-750 (-3.38%)
Nov 20, 2026, 3:30 PM KST
NeoPharm CO., LTD. Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, NeoPharm CO., LTD. stock has a consensus rating of "Strong Buy" and an average price target of ₩30,500. The average 1-year stock price forecast is 42.19% higher than the current stock price, while the lowest is ₩30,000 (+39.86%) and the highest is ₩31,000 (+44.52%).
Price Target: ₩30,500 (+42.19%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for NeoPharm CO., LTD. stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Jun '26 | Jul '26 | Aug '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 2 | 2 |
Financial Forecast
Revenue This Year
166.90B
from 132.18B
Increased by 26.26%
Revenue Next Year
211.50B
from 166.90B
Increased by 26.72%
EPS This Year
2.07K
from 1.78K
Increased by 16.27%
EPS Next Year
2.60K
from 2.07K
Increased by 25.62%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is KRW.